Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol vs Hyaluronic Acid in Diabetic Dry Eye
NCT05682547Completed
- Sponsor
- He Eye Hospital
- Start
- Dec 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of diquafosol in dry eye disease (DED) (2 arms), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at 8 weeks. Started Dec 2022; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05682547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05682547.